Zobrazeno 1 - 10
of 224
pro vyhledávání: '"Takeshi, Tsuda"'
Autor:
Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizusihima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Minehiko Inomata
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background Pulmonary sarcomatoid carcinoma is a rare tumor that is resistant to cytotoxic agents. This observational study aimed to evaluate the detection rate of driver gene alteration and the efficacy of targeted therapy for pulmonary sarc
Externí odkaz:
https://doaj.org/article/0daef32daf774bb8b141fae7e8643c1d
Autor:
Antonio Tapia-Galisteo, Iñigo Sánchez-Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Álvarez-Vallina, Laura Sanz
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
T cell-based immunotherapies for solid tumors have not achieved the clinical success observed in hematological malignancies, partially due to the immunosuppressive effect promoted by the tumor microenvironment, where PD-L1 and TGF-β play a pivotal r
Externí odkaz:
https://doaj.org/article/3126feeb469c436b90c0b4d00590133a
Autor:
Takeshi Tsuda, Gina Patel
Publikováno v:
American Heart Journal Plus, Vol 42, Iss , Pp 100392- (2024)
Coronary microvascular dysfunction (CMD) encompasses a spectrum of structural and functional alterations in coronary microvasculature resulting in impaired coronary blood flow and consequent myocardial ischemia without obstruction in epicardial coron
Externí odkaz:
https://doaj.org/article/769fefcb7aa743b7bb375b33715f3534
Publikováno v:
Cardio-Oncology, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Background Asymptomatic childhood cancer survivors (CCS) frequently show decreased exercise performance. Poor exercise performance may indicate impaired future cardiovascular health. Methods Cardiopulmonary exercise testing (CPET) was perfor
Externí odkaz:
https://doaj.org/article/eb38d375fdee41a586dc71a65580297d
Autor:
Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai, Takayuki Kishikawa, Ken Masubuchi, Takashi Osaki, Yosuke Miura, Yukihiro Umeda, Akihiro Ono, Hiroyuki Minemura, Yutaka Yamada, Junichi Nakagawa, Yuki Kozu, Hirokazu Taniguchi, Hiromitsu Ohta, Takashi Kasai, Kyoichi Kaira, Hiroshi Kagamu
Publikováno v:
Thoracic Cancer, Vol 14, Iss 25, Pp 2567-2578 (2023)
Abstract Background Factors predicting the response to pembrolizumab plus platinum and pemetrexed combination therapy (Pemb‐Plt‐PEM) in nonsquamous non‐small cell lung cancer (non‐sq NSCLC) are unclear. We investigated the Glasgow Prognostic
Externí odkaz:
https://doaj.org/article/94316acf290f494398a776598e298791
Autor:
Koichi Tamura, Yukinori Takenaka, Kiyohito Hosokawa, Takashi Sato, Takeshi Tsuda, Hirotaka Eguchi, Masami Suzuki, Takahito Fukusumi, Motoyuki Suzuki, Hidenori Inohara
Publikováno v:
PLoS ONE, Vol 19, Iss 11, p e0314209 (2024)
Immune checkpoint inhibitors (ICIs) are pharmacological agents indicated for recurrent and metastatic head and neck squamous cell carcinoma (HNCSCC). Immune-related adverse events (irAEs) have been reported as predictors of therapeutic response to IC
Externí odkaz:
https://doaj.org/article/c1d2a5f7575f485d9bb302dd4f13fcd0
Publikováno v:
Brazilian Journal of Otorhinolaryngology, Vol 90, Iss 1, Pp 101339- (2024)
Externí odkaz:
https://doaj.org/article/6bea19dda7564afba7596e95e0c44be2
Autor:
Minehiko Inomata, Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizushima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Kazuyuki Tobe
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1618-1623 (2023)
Abstract Objective Studies have suggested the potential efficacy of immune checkpoint inhibitors (ICIs) for pulmonary sarcomatoid carcinoma. This multicenter observational study was conducted to evaluate the efficacy of systemic ICI therapy and chemo
Externí odkaz:
https://doaj.org/article/d017de19d4e6443389f1d93a76555a9a
Autor:
Ayaka Nakatani, Takeshi Tsuda, Yohei Maeda, Masaki Hayama, Daisuke Okuzaki, Sho Obata, Toshihiro Kishikawa, Kazuya Takeda, Hidenori Inohara
Publikováno v:
Allergology International, Vol 72, Iss 1, Pp 143-150 (2023)
Background: Chronic rhinosinusitis is classified into eosinophilic chronic rhinosinusitis (ECRS) and non-eosinophilic chronic rhinosinusitis (NECRS). ECRS is a refractory allergic disease involving a variety of immune and epithelial cells. S100A8 is
Externí odkaz:
https://doaj.org/article/0520ba24a0594cdda50aeb8c628cbc13
Autor:
Ayako Shiono, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai, Hiroyuki Minemura, Yutaka Yamada, Takayuki Kishikawa, Yukihiro Umeda, Hiroki Takechi, Ou Yamaguchi, Atsuto Mouri, Kyoichi Kaira, Hirokazu Taniguchi, Koichi Minato, Hiroshi Kagamu
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 73-83 (2023)
Abstract Purpose The aim of this study was to assess the effectiveness and tolerability of atezolizumab plus carboplatin and etoposide combination chemotherapy in elderly patients with extensive‐disease (ED) small‐cell lung cancer (SCLC). Methods
Externí odkaz:
https://doaj.org/article/7b714a5a6ae74295a24b9195992b391e